BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 35875167)

  • 21. Machine learning-based radiomics strategy for prediction of acquired EGFR T790M mutation following treatment with EGFR-TKI in NSCLC.
    Lu J; Ji X; Liu X; Jiang Y; Li G; Fang P; Li W; Zuo A; Guo Z; Yang S; Ji Y; Lu D
    Sci Rep; 2024 Jan; 14(1):446. PubMed ID: 38172228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative prediction for lauren type of gastric cancer: A radiomics nomogram analysis based on CT images and clinical features.
    Sun Z; Jin L; Zhang S; Duan S; Xing W; Hu S
    J Xray Sci Technol; 2021; 29(4):675-686. PubMed ID: 34024809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of response to neoadjuvant chemotherapy in advanced gastric cancer: A radiomics nomogram analysis based on CT images and clinicopathological features.
    Tan X; Yang X; Hu S; Ge Y; Wu Q; Wang J; Sun Z
    J Xray Sci Technol; 2023; 31(1):49-61. PubMed ID: 36314190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic analysis and risk stratification of lung adenocarcinoma undergoing EGFR-TKI therapy with time-serial CT-based radiomics signature.
    Zhang X; Lu B; Yang X; Lan D; Lin S; Zhou Z; Li K; Deng D; Peng P; Zeng Z; Long L
    Eur Radiol; 2023 Feb; 33(2):825-835. PubMed ID: 36166088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI-based multiregional radiomics for predicting lymph nodes status and prognosis in patients with resectable rectal cancer.
    Li H; Chen XL; Liu H; Lu T; Li ZL
    Front Oncol; 2022; 12():1087882. PubMed ID: 36686763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the generation of EGFR-TKIs administered as prior therapy on the efficacy of osimertinib in patients with non-small cell lung cancer harboring EGFR T790M mutation.
    Miyashita Y; Ko R; Shimada N; Mitsuishi Y; Miura K; Matsumoto N; Asao T; Shukuya T; Shibayama R; Koyama R; Takahashi K
    Thorac Cancer; 2021 Feb; 12(3):329-338. PubMed ID: 33219754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prediction of platinum-based chemotherapy sensitivity for epithelial ovarian cancer by multi-sequence MRI-based radiomic nomogram].
    Mao MM; Li HM; Shi J; Qiu QS; Feng F
    Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):201-208. PubMed ID: 35042289
    [No Abstract]   [Full Text] [Related]  

  • 28. MRI radiomics predicts the efficacy of EGFR-TKI in EGFR-mutant non-small-cell lung cancer with brain metastasis.
    Qi H; Hou Y; Zheng Z; Zheng M; Sun X; Xing L
    Clin Radiol; 2024 Jul; 79(7):515-525. PubMed ID: 38637187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Osimertinib After Progression of First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (
    Xu Z; Hao X; Wang Q; Wang J; Yang K; Wang S; Teng F; Li J; Xing P
    Cancer Manag Res; 2022; 14():863-873. PubMed ID: 35256860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
    Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin Kinase Inhibitor Therapy.
    Weng Q; Hui J; Wang H; Lan C; Huang J; Zhao C; Zheng L; Fang S; Chen M; Lu C; Bao Y; Pang P; Xu M; Mao W; Wang Z; Tu J; Huang Y; Ji J
    Front Oncol; 2021; 11():590937. PubMed ID: 34422624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma.
    Hong D; Xu K; Zhang L; Wan X; Guo Y
    Front Oncol; 2020; 10():28. PubMed ID: 32082997
    [No Abstract]   [Full Text] [Related]  

  • 33. Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.
    Sun Y; Li C; Jin L; Gao P; Zhao W; Ma W; Tan M; Wu W; Duan S; Shan Y; Li M
    Eur Radiol; 2020 Jul; 30(7):3650-3659. PubMed ID: 32162003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiomics-clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma.
    Ding J; Li Z; Lin Y; Huang C; Chen J; Hong J; Fei Z; Zhou Q; Chen C
    Sci Rep; 2023 Oct; 13(1):18167. PubMed ID: 37875498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiomics Nomogram Based on Contrast-enhanced CT to Predict the Malignant Potential of Gastrointestinal Stromal Tumor: A Two-center Study.
    Song Y; Li J; Wang H; Liu B; Yuan C; Liu H; Zheng Z; Min F; Li Y
    Acad Radiol; 2022 Jun; 29(6):806-816. PubMed ID: 34238656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical-Radiomics Nomogram Based on Contrast-Enhanced Ultrasound for Preoperative Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Jiang L; Zhang Z; Guo S; Zhao Y; Zhou P
    Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.
    Jiang X; Ren M; Shuang X; Yang H; Shi D; Lai Q; Dong Y
    J Magn Reson Imaging; 2021 Aug; 54(2):497-507. PubMed ID: 33638577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma.
    Cao R; Dong Y; Wang X; Ren M; Wang X; Zhao N; Yu T; Zhang L; Luo Y; Cui EN; Jiang X
    Acad Radiol; 2022 Mar; 29(3):e9-e17. PubMed ID: 34332860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiomics Analysis of PET and CT Components of
    Wang X; Lu Z
    Front Oncol; 2021; 11():638124. PubMed ID: 33928029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
    Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
    Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.